JENNIFER HEMMELGARN: Open Payments
NPI 1720394208 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 27 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $549 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $321 |
| Novo Nordisk Inc | 2 | $38 |
| Astellas Pharma US Inc | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Veozah, VOQUEZNA, FREESTYLE LIBRE 3, Wegovy, OTEZLA.
Industry payments across IL — which companies pay providers there.
